[ad_1] Wall Street brokers predict Crispr Therapeutics AG (NASDAQ: CRSP) to report earnings per share of $ 0.65 for the quarter Zacks Investment Research Three badysts provided estimates for the benefit of …
Read More »– $ 0.65 expected earnings per share for Crispr Therapeutics AG (CRSP) this quarter
